Pyridam Farma Tbk - Asset Resilience Ratio

Latest as of September 2025: 0.02%

Pyridam Farma Tbk (PYFA) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PYFA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rp1.24 Billion

≈ $72.53K USD Cash + Short-term Investments

Total Assets

Rp6.92 Trillion

≈ $405.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2024)

This chart shows how Pyridam Farma Tbk's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Pyridam Farma Tbk asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Pyridam Farma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Pyridam Farma Tbk for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp0.00	0%
Short-term Investments	Rp1.24 Billion	0.02%
Total Liquid Assets	Rp1.24 Billion	0.02%

Asset Resilience Insights

Limited Liquidity: Pyridam Farma Tbk maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pyridam Farma Tbk Industry Peers by Asset Resilience Ratio

Compare Pyridam Farma Tbk's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%

Annual Asset Resilience Ratio for Pyridam Farma Tbk (2001–2024)

The table below shows the annual Asset Resilience Ratio data for Pyridam Farma Tbk.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.03%	Rp1.64 Billion ≈ $96.20K	Rp5.81 Trillion ≈ $340.51 Million	--
2023-12-31	0.00%	Rp0.00 ≈ $0.00	Rp1.52 Trillion ≈ $89.14 Million	--
2018-12-31	1.04%	Rp1.95 Billion ≈ $114.46K	Rp187.06 Billion ≈ $10.96 Million	+0.81pp
2017-12-31	0.24%	Rp379.65 Million ≈ $22.25K	Rp159.56 Billion ≈ $9.35 Million	-0.58pp
2016-12-31	0.82%	Rp1.37 Billion ≈ $79.99K	Rp167.06 Billion ≈ $9.79 Million	+0.74pp
2003-12-31	0.07%	Rp51.00 Million ≈ $2.99K	Rp68.27 Billion ≈ $4.00 Million	-5.47pp
2001-12-31	5.54%	Rp4.25 Billion ≈ $249.03K	Rp76.67 Billion ≈ $4.49 Million	--

pp = percentage points

About Pyridam Farma Tbk

JK:PYFA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$138.27 Million

Rp2.36 Trillion IDR

Market Cap Rank

#18028 Global

#281 in Indonesia

Share Price

Rp210.00

Change (1 day)

-5.41%

52-Week Range

Rp171.00 - Rp630.00

All Time High

Rp1480.00